期刊文献+

辣椒素对文拉法辛药动学影响研究 被引量:3

The effects of capsaicin on pharmacokinetics of venlafaxine
原文传递
导出
摘要 目的:考察辣椒素对文拉法辛及其活性代谢物O-去甲基文拉法辛体内药动学的影响。方法:选取10只健康SD大鼠,采用自身对照方法,考察单剂量给予盐酸文拉法辛(20.25 mg·kg-1)(对照组)以及连续7 d灌胃辣椒素后再给予盐酸文拉法辛(实验组)的药动学差异。采用已验证的液相色谱-串联质谱法(LC-MS/MS)测定血浆中文拉法辛及O-去甲基文拉法辛的浓度,经DAS 3.2.4软件计算药动学参数,SPSS软件计算两组实验的差异是否具有显著性。结果:对照组和实验组大鼠血浆中文拉法辛的AUC0-10、Cmax、Tmax、 t1/2分别为(780.81±709.76)μg·L-1·h-1和(1037.84±582.63)μg·L-1·h-1、(517.57±462.46)μg·L-1和(876.64±301.79)μg·L-1、(0.32±0.20) h和(0.25±0.09) h、(1.00±0.84) h和(0.89±0.18) h;O-去甲基文拉法辛的AUC0-10、Cmax、Tmax、 t1/2分别为(163.60±77.93)μg·L-1·h-1和(240.41±62.69)μg·L-1·h-1、(96.83±46.51)μg·L-1和(182.52±46.40)μg·L-1、(0.46±0.30) h和(0.25±0.06) h、(1.19±0.32) h和(2.65±1.58)h;其中实验组的AUC0-10、Cmax均增加,差异具有显著性。结论:辣椒素增加文拉法辛的吸收,提高生物利用度,即能影响文拉法辛的体内药动学过程。 OBJECTIVE To investigate the effect of capsaicin on the pharmacokinetics of venlafaxine and its active metabolite O-desmethyl venlafaxine. METHODS enlafaxine hydr-ochloride was given to 10 healthy SD rats at a single dose(20.25 mg·kg^-1)(control group) and then capsaicin wasere given for 7 days(test group) to observe pharmacokinetic differences by using self-control method. The plasma concentrations of venlafaxine and O-desmethyl venlafaxine were determined by verified liquid chromatography-tandem mass spectrometry(LC-MS/MS). The pharmacokinetic parameters were calculated by DAS 3.2.4 software, and through SPSS software to find out whether the two groups had statistically significance. RESULTS The AUC0-10, Cmax, Tmax, and t1/2 of plasma venlafaxine in rats of the control and experimental groups were(780.81±709.76) μg·L-1·h-1 and(1 037.84±582.63) μg·L^-1·h^-1,(517.57±462.46) μg·L^-1 and(876.64±301.79) g·L^-1,(0.32±0.20) h and(0.25±0.09) h,(1.00±0.84) h and(0.89±0.18) h, respectively. One the other hand, the AUC0-10, Cmax, Tmax, and t1/2of plasma O-desmethyl venlafaxine in rats of the control and experimental groups were(163.60±77.93) g·L^-1·h^-1 and(240.41±62.69) μg·L^-1·h^-1,(96.83±46.51) μg·L^-1 and(182.52±46.40) μg·L^-1,(0.46±0.30) h and(0.25±0.06) h,(1.19±0.32) h and(2.65±1.58) h, respectively. Both AUC0-10 and Cmax were increased in test group, and the difference had statistical significance. CONCLUSION Capsaicin increases the absorption and the bioavailability of venlafaxine, so it can affect the in vivo pharmacokinetics of venlafaxine.
作者 胡礼军 张明 陈雨晴 谢焕山 王占璋 卢浩扬 倪晓佳 尚德为 温预关 HU Li-jun;ZHANG Ming;CHEN Yu-qing;XIE Huan-shan;WANG Zhan-zhang;LU Hao-yang;NI Xiao-jia;SHANG De-wei;WEN Yu-guan(The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital),Guangdong Engineering Technology Research Center for Translational Medicine of Metal Disorders,Guangzhou Guangdong 510370,China;Department of Pharmacy,Changde Vocational Technical College, Department of Pharmacy,Changde Hunan Changde 415000,China)
出处 《中国医院药学杂志》 CAS 北大核心 2019年第2期142-145,共4页 Chinese Journal of Hospital Pharmacy
基金 广州市医药卫生科技项目(编号:20161A010045) 广州市科技计划项目创新平台建设计划"广州市精神疾病临床转化实验室"(编号:201805010009)
关键词 文拉法辛 O-去甲基文拉法辛 辣椒素 LC-MS/MS 药动学 venlafaxine O-desmethyl venlafaxine capsaicin LC-MS/MS pharmacokinetics
  • 相关文献

参考文献5

二级参考文献92

  • 1梁晨,韩盛玺.辣椒素临床应用的研究进展[J].华西药学杂志,2008,23(2):185-187. 被引量:17
  • 2黄素培,潘保中,蒋立新.住院精神病患者抗抑郁剂应用分析[J].临床心身疾病杂志,2005,11(1):57-59. 被引量:3
  • 3王灿,陈素,刘向明.龙血素B抑制大鼠背根神经节细胞辣椒素诱发的电流反应[J].中国药理学通报,2007,23(2):211-214. 被引量:11
  • 4Martini C, Yassen A, Olofsen E, et al. Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Quten- za) in diabetic neuropathic pain patients: detection of distinct response groups[J ]. J Pain Res,2012, 5(3):51-59.
  • 5Anandakumar P, Kamaraj S, Jagan S, et al. Capsaicin allevi- ates the imbalance in xenobiotic metabolizing enzymes and tu- mor markers during experimental lung tumorigenesis [J]. Mol Cell Biochem, 2009,331 ( 1/2 ): 135-143.
  • 6Duan L, Yan Y,Sun YB,et al.Contribution of TRPV1 and mul- tidrug resistance proteins in the permeation of capsaicin across different intestinal regions [J]. Int J Pharm, 2013, 445(1/2): 134-140.
  • 7Nimmerfall F, Rosenthaler J. Significance of the goblet-cell rnuein layer, the outermost luminal barrier to passage through the gut wall [J]. Biochem Biophys Res Commun, 1980,94(3): 960-966.
  • 8赵娟,徐叶萍,罗瑾,等.乌鲁木齐市第四人民医院2012-2014年抗抑郁药销售情况分析[J].医药前沿,2015,5(18):323.
  • 9Association AP.Practice guideline for the treatment of patients with major depressive disorder:third edition[S].2010-10-10.
  • 10Fournier JC,Derubeis RJ,Hollon SD,et al.Antidepressant drug effects and depression severity:a patient-level meta-analysis[J].JAMA,2010,303(1):47.

共引文献29

同被引文献53

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部